Inclisiran

Drug

About

Thing
Inclisiran is an experimental drug for the treatment of elevated cholesterol, more specifically familial hypercholesterolaemia. It is a small interfering RNA that inhibits translation of the protein PCSK9. It is being developed by The Medicines Company which licensed the rights to inclisiran from Alnylam Pharmaceuticals. In 2019 The Medicines Company announced positive results from pivotal phase III study.
Inclisiran
Definition
Inclisiran is an experimental drug for the treatment of elevated cholesterol, more specifically familial hypercholesterolaemia. It is a small interfering RNA that inhibits translation of the protein PCSK9. It is being developed by The Medicines Company which licensed the rights to inclisiran from Alnylam Pharmaceuticals. In 2019 The Medicines Company announced positive results from pivotal phase III study.
Inclisiran
Inclisiran
Inclisiran is an experimental drug for the treatment of elevated cholesterol, more specifically familial hypercholesterolaemia. It is a small interfering RNA that inhibits translation of the protein PCSK9. It is being developed by The Medicines Company which licensed the rights to inclisiran from Alnylam Pharmaceuticals. In 2019 The Medicines Company announced positive results from pivotal phase III study.

See also

See also: